VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

bortezomib

Trial Locations (1)

46254

Investigative Clinical Research of Indiana, LLC, Indianapolis

All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Millennium Pharmaceuticals, Inc.

INDUSTRY